Your browser is no longer supported. Please, upgrade your browser.
Settings
ISR IsoRay, Inc. daily Stock Chart
ISR [NYSE]
IsoRay, Inc.
Index- P/E- EPS (ttm)-0.10 Insider Own0.30% Shs Outstand55.08M Perf Week7.32%
Market Cap33.60M Forward P/E61.00 EPS next Y0.01 Insider Trans13.77% Shs Float54.42M Perf Month10.71%
Income-5.50M PEG- EPS next Q-0.01 Inst Own7.20% Short Float3.78% Perf Quarter9.30%
Sales4.50M P/S7.47 EPS this Y-27.60% Inst Trans-13.76% Short Ratio23.96 Perf Half Y-2.70%
Book/sh0.22 P/B2.77 EPS next Y111.10% ROA-34.60% Target Price3.00 Perf Year-25.15%
Cash/sh0.19 P/C3.23 EPS next 5Y- ROE-38.50% 52W Range0.48 - 0.84 Perf YTD5.17%
Dividend- P/FCF- EPS past 5Y5.40% ROI-33.80% 52W High-30.79% Beta0.87
Dividend %- Quick Ratio10.20 Sales past 5Y-1.90% Gross Margin6.50% 52W Low20.83% ATR0.03
Employees41 Current Ratio10.50 Sales Q/Q8.30% Oper. Margin- RSI (14)47.83 Volatility4.31% 5.39%
OptionableNo Debt/Eq0.00 EPS Q/Q-13.80% Profit Margin- Rel Volume0.62 Prev Close0.61
ShortableYes LT Debt/Eq0.00 EarningsAug 09 AMC Payout- Avg Volume85.85K Price0.58
Recom2.00 SMA20-3.15% SMA501.03% SMA200-1.20% Volume53,482 Change-4.92%
Nov-10-15Reiterated Maxim Group Buy $5 → $3
Jul-16-14Resumed Maxim Group Buy $3.50 → $5
Apr-02-14Reiterated Maxim Group Buy $1.50 → $3.50
Nov-01-13Initiated Maxim Group Buy $1.50
Mar-17-10Initiated C.K. Cooper Buy $1.70
Aug-21-08Downgrade Ladenburg Thalmann Buy → Neutral
May-14-08Reiterated Ladenburg Thalmann Buy $2 → $1.50
Feb-13-08Reiterated Punk, Ziegel & Co Buy $6.25 → $2
Sep-24-07Initiated Punk, Ziegel & Co Buy $6.25
Jul-07-17 08:00AM  IsoRay Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer PR Newswire
Jul-06-17 08:00AM  IsoRay Receives FDA Response to 510(k) Application for GammaTile PR Newswire
Jun-20-17 08:00AM  IsoRay Announces Study Published in The International Journal of Radiation Oncology, Biology, Physics entitled, "Clinical Outcomes of Large Brain Metastases Treated with Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial" PR Newswire
Jun-09-17 01:40PM  ETFs with exposure to IsoRay, Inc. : June 9, 2017 Capital Cube
May-30-17 12:31PM  ETFs with exposure to IsoRay, Inc. : May 30, 2017 Capital Cube
May-26-17 09:25AM  IsoRay, Inc. :ISR-US: Earnings Analysis: Q3, 2017 By the Numbers : May 26, 2017 Capital Cube
May-10-17 08:20AM  IsoRay reports 3Q loss Associated Press
08:00AM  IsoRay Announces Third Quarter Fiscal 2017 Financial Results PR Newswire
May-03-17 08:00AM  IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled "Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131" PR Newswire +5.24%
Apr-27-17 04:05PM  ETFs with exposure to IsoRay, Inc. : April 27, 2017 Capital Cube
Apr-18-17 08:00AM  IsoRay, Inc. to Present at the Planet MicroCap Showcase 2017 Accesswire -7.21%
Apr-07-17 04:55PM  ETFs with exposure to IsoRay, Inc. : April 7, 2017 Capital Cube
Mar-27-17 04:00PM  ETFs with exposure to IsoRay, Inc. : March 27, 2017 Capital Cube
04:00PM  ETFs with exposure to IsoRay, Inc. : March 27, 2017
Mar-21-17 09:28AM  IsoRay, Inc. :ISR-US: Earnings Analysis: Q2, 2017 By the Numbers : March 21, 2017 Capital Cube
09:28AM  IsoRay, Inc. :ISR-US: Earnings Analysis: Q2, 2017 By the Numbers : March 21, 2017
Mar-10-17 07:20AM  ISORAY, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-09-17 04:05PM  IsoRay Announces Final Court Approval of Class Action Settlement PR Newswire
Mar-03-17 04:39PM  ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Feb-15-17 01:04PM  ISORAY, INC. Financials
Feb-09-17 04:36PM  ISORAY, INC. Files SEC form 10-Q, Quarterly Report
Feb-08-17 05:34PM  IsoRay reports 2Q loss Associated Press
04:33PM  ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IsoRay Announces Second Quarter Fiscal 2017 Financial Results PR Newswire
Feb-07-17 08:30AM  MicroCap Review Magazine Winter/Spring 2017 Issue Now Available PR Newswire
Feb-03-17 04:33PM  ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Secur
Feb-02-17 09:25AM  IsoRay, Inc. to Present at the 2nd Annual Disruptive Growth & Healthcare Conference Accesswire
Jan-23-17 04:32PM  ISORAY, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers
Jan-19-17 01:11PM  ETFs with exposure to IsoRay, Inc. : January 19, 2017 Capital Cube
01:11PM  ETFs with exposure to IsoRay, Inc. : January 19, 2017
Jan-17-17 06:23AM  ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal Officers -9.14%
Jan-11-17 07:19AM  Purcell Julie & Lefkowitz LLP Is Investigating IsoRay, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Jan-06-17 11:50AM  ETFs with exposure to IsoRay, Inc. : January 6, 2017
Dec-28-16 04:37PM  ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Dec-22-16 08:30AM  IsoRay Medical, Inc. Discusses Cesium-131 and its Applications in New SNNLive Video Interview on StockNewsNow.com PR Newswire
Dec-21-16 12:30PM  ETFs with exposure to IsoRay, Inc. : December 21, 2016 +14.86%
08:30AM  IsoRay, Inc. Announces the Launch of a Pilot Study Using Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Resectable High Risk Recurrent Head and Neck Cancer by Case Comprehensive Cancer Center PR Newswire
Dec-20-16 04:31PM  ISORAY, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Dec-07-16 11:30AM  ETFs with exposure to IsoRay, Inc. : December 7, 2016 +7.27%
Dec-05-16 04:33PM  ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-30-16 09:00AM  IsoRay to Present at 9th Annual LD Micro Investor Conference PR Newswire
Nov-29-16 09:00AM  IsoRay Announces "Cesium-131 Brachytherapy for Salvage of Recurrent High Grade Glioma" Poster Presentation at 21st Annual Scientific Meeting of Society for Neuro-Oncology PR Newswire
Nov-18-16 01:15PM  ETFs with exposure to IsoRay, Inc. : November 18, 2016
Nov-14-16 11:54AM  IsoRay, Inc. :ISR-US: Earnings Analysis: Q1, 2017 By the Numbers : November 14, 2016
Nov-09-16 06:05AM  ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Nov-08-16 06:39PM  IsoRay Announces First Quarter Fiscal 2017 Financial Results PR Newswire
Oct-30-16 08:00AM  The Rosen Law Firm, P.A. and Wolf Haldenstein Adler Freeman & Herz LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of IsoRay, Inc. -- ISR GlobeNewswire
Oct-21-16 06:02AM  ISORAY, INC. Files SEC form 8-K, Other Events
Oct-20-16 04:15PM  IsoRay, Inc. Announces Date for Fiscal 2017 Annual Meeting and Shareholder Record Date PR Newswire
Oct-07-16 10:01AM  ETFs with exposure to IsoRay, Inc. : October 7, 2016
Sep-28-16 06:00AM  IsoRay, Inc. Announces Launch of Newly Redesigned Patient and Clinician Focused Corporate Website PR Newswire
Sep-27-16 06:06AM  ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat
06:00AM  IsoRay, Inc. Enters Into Agreement to Settle Class Action Shareholder Litigation PR Newswire
Sep-23-16 11:38AM  IsoRay, Inc. :ISR-US: Earnings Analysis: 2016 By the Numbers : September 23, 2016
Sep-20-16 10:33AM  ETFs with exposure to IsoRay, Inc. : September 20, 2016
Sep-09-16 09:26AM  ISORAY, INC. Files SEC form 10-K, Annual Report
Sep-08-16 06:30PM  IsoRay Announces Fourth Quarter and Year End Fiscal 2016 Financial Results PR Newswire
05:26PM  ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Aug-16-16 09:00AM  IsoRay, Inc. to Present at Rodman & Renshaw 18th Annual Global Investment Conference PR Newswire
Aug-11-16 12:52PM  ETFs with exposure to IsoRay, Inc. : August 11, 2016
Jul-08-16 05:23PM  ISORAY, INC. Files SEC form 8-K, Other Events
Jul-06-16 08:45AM  Women's Cancer and Cesium-131 Treatments: Topic of Two Presentations at the 2016 Annual Meeting of the American Brachytherapy Society and World Congress of Brachytherapy PR Newswire
Jun-24-16 06:06AM  ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jun-21-16 02:07PM  Heres Why These Five Stocks Are Trending Today at Insider Monkey +15.63%
06:30AM  IsoRay® Announces Results of Prospective Trial Presented at Society of Neuro-Oncology Conference PR Newswire
Jun-16-16 02:31AM  ISRA VISION AG :ISR-DE: Earnings Analysis: Q2, 2016 By the Numbers : June 16, 2016
Jun-13-16 06:08AM  ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Securi
Jun-02-16 04:20PM  Court Issues Ruling on IsoRay Motion to Dismiss Securities Lawsuit PR Newswire
May-17-16 03:05PM  IsoRay, Inc. :ISR-US: Earnings Analysis: Q3, 2016 By the Numbers -17.48%
May-16-16 09:00AM  IsoRay Provides Update on Motion to Dismiss Securities Lawsuit PR Newswire
May-10-16 05:01PM  ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:07PM  ISORAY, INC. Files SEC form 10-Q, Quarterly Report
04:05PM  IsoRay Announces Third Quarter Fiscal 2016 Financial Results and Early Conclusions from Ongoing Strategic Review Process PR Newswire
Apr-12-16 05:19PM  ISORAY, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement
Apr-08-16 04:30PM  IsoRay, Inc. Announces Annual Meeting and Shareholder Record Dates PR Newswire
Mar-18-16 02:48PM  Meet the Biotech Company About to Turn the 120-Year-Old Cancer Radiation Industry on Its Head Accesswire
Mar-03-16 05:52PM  ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-02-16 08:30AM  IsoRay Appoints Michael L. Krachon as Vice President of Sales and Marketing and Lori A. Woods as Senior Marketing Consultant PR Newswire
Feb-19-16 05:17PM  ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Feb-16-16 01:59PM  IsoRay, Inc. Earnings Analysis: Q2, 2016 By the Numbers
Feb-10-16 08:16AM  ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:00AM  IsoRay Reports Second Quarter Fiscal 2016 Financial Results PR Newswire
Feb-09-16 05:15PM  ISORAY, INC. Files SEC form 10-Q, Quarterly Report
Jan-15-16 04:32PM  ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Ex
Jan-14-16 08:00AM  IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15 PR Newswire
Jan-13-16 08:00AM  Clinical Study Discusses Cost Effectiveness of Surgical Resection and IsoRay's Cesium-131 Intraoperative Brachytherapy PR Newswire
Jan-12-16 05:01PM  ISORAY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Ex
Jan-07-16 08:00AM  IsoRay Chairman and CEO Dwight Babcock to Retire PR Newswire
Dec-31-15 04:03PM  ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Dec-21-15 04:02PM  ISORAY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Dec-17-15 11:04AM  IsoRay, Inc. Earnings Analysis: Q1, 2016 By the Numbers
Dec-16-15 08:30AM  Weill Cornell Medical Clinical Study Demonstrates Cesium-131 Brachytherapy Seeds on a String Surgical Technique Promotes Dose Homogeneity and Minimizes the Risk of Radiation-Induced Injury Marketwired
Dec-14-15 08:30AM  Weill Cornell Clinical Study Notes Cesium-131 Brachytherapy Can Provide a Viable Alternative to Whole Brain Radiotherapy With Excellent Response Rates and Minimal Toxicity Marketwired
Nov-10-15 08:31AM  ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:30AM  IsoRay Reports First Quarter Fiscal 2016 Financial Results Marketwired
Nov-09-15 05:59PM  ISORAY, INC. Files SEC form 10-Q, Quarterly Report -7.69%
Oct-14-15 08:15AM  IsoRay's Proprietary Cesium-131 Product Line Will Be on Display at the American Society for Radiation Oncology (ASTRO) Convention Marketwired
Oct-01-15 10:34AM  IsoRay, Inc. Earnings Q4, 2015
Sep-15-15 08:46AM  ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -5.23%
08:15AM  IsoRay, Inc. Reports 9% Revenue Increase for Fiscal Year 2015 Marketwired
IsoRay, Inc. develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. The company was formerly known as Century Park Pictures Corporation and changed its name to IsoRay, Inc. in 2005. IsoRay, Inc. was founded in 1983 and is headquartered in Richland, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LAVOY THOMAS CCEOMar 10Buy0.5320,00010,600183,523Mar 13 07:11 PM
Vitale Philip JDirectorJan 04Buy0.6620,00013,18640,000Jan 06 05:38 PM
Hoffmann AlanDirectorDec 08Buy0.5720,00011,40020,000Dec 13 07:27 PM
LAVOY THOMAS CCEONov 17Buy0.6020,00012,000163,523Nov 21 08:30 PM